exposure). 
This change was aimed at simpliﬁ  cation of the recommendation to improve uptake and 
completion rates for PEP. This shift towards recommending a three-drug regimen for everyone was based on the availability of less toxic and better-tolerated medications, the difﬁ  culty in evaluating the risk of drug resistance and need to simplify prescribing.
Follow up
HIV antibody testing should be done for at least 6 months post-exposure (e.g. at baseline, 6 weeks, 3 months, and 6 months) to ensure no transmission has occurred.
Prophylaxis for HBV
x HCWs have a higher risk of exposure to HBV infection than the general population, hence 
routine vaccination against HBV is necessary for personnel who are likely to come in contact with blood, body ﬂ  uids or sharps.